Patient Safety Blog

Strengthening Patient Safety Through Practical Supplier Quality Oversight | Insights from an Rx‑360 Supplier Quality Working Group Informal Survey

May 28, 2026

Ensuring patient safety depends on the integrity of global pharmaceutical supply chains—yet Supplier Quality professionals continue to face practical, structural challenges in how audits are conducted, documented, and leveraged for assurance.   To better understand current practices, Rx‑360 […]

Interactive Resources

Supplier Corrective Action Report Web Form

January 12, 2026

Optimize Supplier Corrective Actions with Rx‑360’s SCAR Template The Supplier Quality Working Group at Rx‑360 has developed a standardized Supplier Corrective Action Report (SCAR) template designed to strengthen pharmaceutical supply chain integrity and improve quality […]

Patient Safety Blog

The BIOSECURE Act and the Quiet Work Ahead for Pharmaceutical Supply Chains

December 22, 2025

The BIOSECURE Act did not arrive with ceremony. It arrived embedded in the National Defense Authorization Act, debated largely in abstractions, and passed with little public attention. But for pharmaceutical and biotechnology companies operating global […]

Publications

Supply Chain Security Toolkit Video Modules

November 6, 2025

Get the tools you need for breaking down the barriers that hold the world back from optimal movement of critical goods and materials. Download the index document to access the video modules listed below that […]

Publications

Supplier Readiness Checklist

October 28, 2025

Use Rx-360’s Supplier Readiness Checklist to ensure that you – the supplier – meet the operational, quality, and compliance standards required industry-leading global pharmaceutical manufacturers. Developed from an industry-leading global pharmaceutical manufacturer’s supplier management standard […]

Patient Safety Blog

Direct-to-Patient Pharmaceutical Programs

October 15, 2025

The pharmaceutical landscape is evolving rapidly, and one of the most transformative shifts is the rise of direct-to-patient (D2P) distribution. As manufacturers seek to bypass traditional channels and deliver medications straight to patients’ doors, the […]